Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

Q2 2015

XLV Guru Trades in Q2 2015

Steven Cohen 6,200 sh (New)
Louis Moore Bacon 520,175 sh (+17.11%)
Ken Fisher 271,515 sh (+5.40%)
Jim Simons Sold Out
Leon Cooperman Sold Out
» More
Q3 2015

XLV Guru Trades in Q3 2015

Ken Fisher 285,985 sh (+5.33%)
Steven Cohen Sold Out
Louis Moore Bacon 73,000 sh (-85.97%)
» More
Q4 2015

XLV Guru Trades in Q4 2015

Jim Simons 53,500 sh (New)
Louis Moore Bacon 89,000 sh (+21.92%)
Ken Fisher 293,541 sh (+2.64%)
Louis Moore Bacon 35,000 sh (unchged)
» More
Q1 2016

XLV Guru Trades in Q1 2016

Ken Fisher 298,675 sh (+1.75%)
» More

Ratios

vs
industry
vs
history
P/E(ttm) 22.55
XLV's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 22.55 )
Ranked among companies with meaningful P/E(ttm) only.
XLV' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 22.76
Current: 22.55
0
22.76
PE(NRI) 22.55
XLV's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 22.55 )
Ranked among companies with meaningful PE(NRI) only.
XLV' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 22.76
Current: 22.55
0
22.76
P/B 3.58
XLV's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 3.58 )
Ranked among companies with meaningful P/B only.
XLV' s P/B Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.65
Current: 3.58
0
3.65

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.52
XLV's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 1.52 )
Ranked among companies with meaningful Dividend Yield only.
XLV' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 1.53
Current: 1.52
0
1.53
Yield on cost (5-Year) 1.53
XLV's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. XLV: 1.53 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
XLV' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 1.53
Current: 1.53
0
1.53

More Statistics

Short Percentage of Float0.00%
52-Week Range $63.52 - 76.62
Shares Outstanding(Mil)99999999.99
» More Articles for XLV

Headlines

Articles On GuruFocus.com
Infinera's CEO Buys Company Shares May 05 2016 
The Art of Speculation May 05 2016 
Matthews China Fund Buys Stake in Alibaba May 05 2016 
Oracle of Omaha Reduces Stake in VeriSign May 05 2016 
Yacktman Funds Comments on Coca-Cola May 04 2016 
Yacktman Funds Comments on 21st Century Fox May 04 2016 
Yacktman Funds Comments on Hengan May 04 2016 
Yacktman Funds Comments on ConocoPhillips May 04 2016 
Yacktman Funds Comments on BNY Mellon May 04 2016 
Yacktman Funds Comments on P&G May 04 2016 

More From Other Websites
Top fund manager on health care May 05 2016
Inside XLV’s Large Caps: Pfizer’s 1Q16 Earnings May 05 2016
Can XLV Maintain Stability in May? May 05 2016
Can the St. Jude Medical-Abbott Deal Get Antitrust Approval? May 05 2016
What Are the Basics of the St. Jude Medical-Abbott Transaction? May 05 2016
Why ‘Tobin’s Q’ Should Make You More Cautious Towards The Stock Market Today May 04 2016
Why ‘Tobin’s Q’ Should Make You More Cautious Towards The Stock Market Today May 04 2016
Rationale for the St. Jude Medical-Abbott Merger Transaction May 04 2016
Abbott Buys St. Jude Medical for $85 per Share in Cash and Stock May 04 2016
No — This Chart Doesn’t Prove This Is The Most Hated Bull Market May 03 2016
Fed’s Dovish Stance – What Does it Mean May 03 2016
Tech-Heavy QQQ ETF Halts Row Of Losses As Amazon Eyes $700 May 02 2016
The Last Week of April Wasn’t Good for Biotechnology Stocks May 02 2016
Technology and Healthcare SPDR Indices Fell Due to Weak Earnings May 02 2016
The Fed Flies Like a Dove Apr 30 2016
LabCorp’s Growth Drivers in 1Q16: Organic Growth, Acquisitions Apr 30 2016
Advance Estimates of U.S. GDP Growth Apr 30 2016
Understanding Regeneron’s Operating Expenses and Margins Apr 29 2016
Apple Drives Selloff on April's Last Trading Day Apr 29 2016
17 Healthcare ETFs Investors Should Check Up On Apr 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK